| 1 |
KEGG mapping tools for uncovering hidden features in biological data
Minoru I. Kanehisa, Yoko Sato, Masayuki Kawashima · Protein Science
Open access |
23 Aug 2021 |
778 |
| 2 |
Cortical thickness across the lifespan: Data from 17,075 healthy individuals aged 3–90 years
Sophia Frangou et al. · Human Brain Mapping
Open access205 authors |
17 Feb 2021 |
308 |
| 3 |
Monitoring of somatic mutations in circulating cell-free DNA by digital PCR and next-generation sequencing during afatinib treatment in patients with lung adenocarcinoma positive for EGFR activating mutations
Eiji Iwama, Kazuko Sakai, Koichi Azuma et al. · Annals of Oncology
Open access |
3 Oct 2016 |
94 |
| 4 |
Criteria for the diagnosis of idiopathic pleuroparenchymal fibroelastosis: A proposal
Kentaro Watanabe, Hiroshi Ishii, Fumiaki Kiyomi et al. · Respiratory Investigation
|
11 Apr 2019 |
92 |
| 5 |
KEGG tools for classification and analysis of viral proteins
Zhao Jin, Yoko Sato, Masayuki Kawashima et al. · Protein Science
Open access |
26 Oct 2023 |
56 |
| 6 |
Exploration of resistance mechanisms for epidermal growth factor receptor‐tyrosine kinase inhibitors based on plasma analysis by digital polymerase chain reaction and next‐generation sequencing
Eiji Iwama, Kazuko Sakai, Koichi Azuma et al. · Cancer Science
Open access |
6 Oct 2018 |
55 |
| 7 |
Alectinib for Patients with ALK Rearrangement–Positive Non–Small Cell Lung Cancer and a Poor Performance Status (Lung Oncology Group in Kyushu 1401)
Eiji Iwama et al. · Journal of Thoracic Oncology
Open access |
24 Feb 2017 |
54 |
| 8 |
Estimating colorectal polyp size with a virtual scale endoscope and visual estimation during colonoscopy: Prospective, preliminary comparison of accuracy
Ryo Shimoda, Takashi Akutagawa, Michito Tomonaga et al. · Digestive Endoscopy
|
20 May 2022 |
38 |
| 9 |
Cessation of nilotinib in patients with chronic myelogenous leukemia who have maintained deep molecular responses for 2 years: a multicenter phase 2 trial, stop nilotinib (NILSt)
Koji Nagafuji, Itaru Matsumura, Takayuki Shimose et al. · International Journal of Hematology
|
19 Sep 2019 |
33 |
| 10 |
Longitudinal monitoring of somatic genetic alterations in circulating cell‐free DNA during treatment with epidermal growth factor receptor–tyrosine kinase inhibitors
Eiji Iwama, Kazuko Sakai, Noriko Hidaka et al. · Cancer
|
10 Sep 2019 |
29 |
| 11 |
Interspecies comparison of alveolar bone biology: Tooth extraction socket healing in mini pigs and mice
Jie Pan, Igor Pilawski, Xue Yuan et al. · Journal of Periodontology
|
29 Apr 2020 |
28 |
| 12 |
Diagnostic Impacts of Clinical Laboratory Based p2PSA Indexes on any Grade, Gleason Grade Group 2 or Greater, or 3 or Greater Prostate Cancer and Prostate Specific Antigen below 10 ng/ml
Kazuto Ito, Akira Yokomizo, Shoji Tokunaga et al. · The Journal of Urology
|
20 Aug 2019 |
25 |
| 13 |
Erlotinib for Non-Small Cell Lung Cancer with Leptomeningeal Metastases: A Phase II Study (LOGIK1101)
Kaname Nosaki, Takeharu Yamanaka, Akinobu Hamada et al. · The Oncologist
Open access |
12 Jul 2020 |
24 |
| 14 |
Expression of the anaphylatoxin C5a receptor in gastric cancer: implications for vascular invasion and patient outcomes
Hidetoshi Nitta, Takayuki Shimose, Yasunori Emi et al. · Medical Oncology
|
29 Sep 2016 |
24 |
| 15 |
Transitional mucosa in human colorectal lesions
Masaki Mori, Reishi Shimono, Yosuke Adachi et al. · Diseases of the Colon & Rectum
|
Jun 1990 |
24 |
| 16 |
A phase 2 trial of durvalumab treatment following radiation monotherapy in patients with non-small cell lung cancer ineligible for stage III chemoradiotherapy: The SPIRAL-RT study
Tadaaki Yamada, Yasuhiro Gotô, Hiroshi Tanaka et al. · European Journal of Cancer
Open access |
22 Oct 2023 |
23 |
| 17 |
A Modified Essen Stroke Risk Score for Predicting Recurrent Cardiovascular Events: Development and Validation
Shigeki Sumi, Hideki Origasa, Kiyohiro Houkin et al. · International Journal of Stroke
|
3 Jul 2012 |
23 |
| 18 |
Predictive factors of mortality of patients with fragility hip fractures at 1 year after discharge: A multicenter, retrospective study in the northern Kyushu district of Japan
Atsushi Kimura et al. · Journal of orthopaedic surgery
Open access |
29 Aug 2019 |
22 |
| 19 |
Pathological changes of finger and toe in patients with vibration syndrome.
Toshinori Hashiguchi, Hiromasa Yanagi, Yasuhiro Kinugawa et al. · PubMed
Open access |
May 1994 |
17 |
| 20 |
Comprehensive geriatric assessment as a useful tool in predicting adverse events in elderly patients with diffuse large B-cell lymphoma
Toshihiro Tanaka, Rika Sakai, Ilseung Choi et al. · Scientific Reports
Open access |
24 Feb 2022 |
15 |
| 21 |
Current state of yusho and prospects for therapeutic strategies
Chikage Mitoma, Hiroshi Uchi, Kiyomi Tsukimori et al. · Environmental Science and Pollution Research
|
Dec 2017 |
15 |
| 22 |
Interregional Interdependence and Regional Economic Growth: An Interregional Input‐Output Analysis of the Kyushu Region
Takahiro Akita, Mitsuhiko Kataoka · Review of Urban and Regional Development Studies
|
Mar 2002 |
15 |
| 23 |
Survival Analysis for Patients with ALK Rearrangement-Positive Non-Small Cell Lung Cancer and a Poor Performance Status Treated with Alectinib: Updated Results of Lung Oncology Group in Kyushu 1401
Eiji Iwama et al. · The Oncologist
Open access |
30 Oct 2019 |
14 |
| 24 |
A Phase II Trial on Osimertinib as a First-Line Treatment for EGFR Mutation-Positive Advanced NSCLC in Elderly Patients: The SPIRAL-0 Study
Yusuke Chihara et al. · The Oncologist
Open access |
Oct 2022 |
13 |
| 25 |
Comparison of in vitro Anticancer Chemosensitivity between Human Squamous Cell Carcinoma and Adenocarcinoma
Tetsuya Kusumoto, Yoshihisa Sakaguchi, Yoshihiko Maehara et al. · Oncology
|
26 Jun 2009 |
13 |
| 26 |
Comparison of the cytokine adsorption ability in continuous renal replacement therapy using polyethyleneimine-coated polyacrylonitrile (AN69ST) or polymethylmethacrylate (PMMA) hemofilters: a pilot single-center open-label randomized control trial
Yoshihiko Nakamura, Hiroki Hatomoto, Shintaro Yamasaki et al. · European journal of medical research
Open access |
30 Jun 2023 |
11 |
| 27 |
Rationale and design of a phase II trial of durvalumab treatment in patients with NSCLC ineligible for stage III chemoradiotherapy following radiation monotherapy (SPIRAL-RT study)
Tadaaki Yamada, Junji Uchino, Yusuke Chihara et al. · Therapeutic Advances in Medical Oncology
Open access |
2020 |
10 |
| 28 |
Clarithromycin Plus Intravenous Immunoglobulin Therapy Can Reduce the Relapse Rate of Kawasaki Disease: A Phase 2, Open‐Label, Randomized Control Study
Etsuro Nanishi et al. · Journal of the American Heart Association
Open access |
Jul 2017 |
10 |
| 29 |
Clinical impact of cancer cachexia on the outcome of patients with non-small cell lung cancer with PD-L1 tumor proportion scores of ≥50% receiving pembrolizumab monotherapy versus immune checkpoint inhibitor with chemotherapy
Hayato Kawachi et al. · OncoImmunology
Open access |
16 Dec 2024 |
9 |
| 30 |
Promoting In-migration and Resettlement in Peripheral Regions of Japan—Background, Conditions, and Challenges:
Shinji Koyanagi · Journal of Geography (Chigaku Zasshi)
Open access |
2016 |
9 |
| 31 |
A prospective study of XELIRI plus bevacizumab as a first-line therapy in Japanese patients with unresectable or recurrent colorectal cancer (KSCC1101)
Koji Ando, Yasunori Emi, Toyokuni Suenaga et al. · International Journal of Clinical Oncology
|
19 May 2017 |
9 |
| 32 |
Visual and Quantitative Interstitial Lung Abnormality Progression in COPDGene
Rachel K. Putman, Jonathan A. Rose, R. San José Estépar et al. · American Journal of Respiratory and Critical Care Medicine
Open access |
28 Jul 2025 |
8 |
| 33 |
Prophylactic Effect of Dexamethasone on Regorafenib-Related Fatigue and/or Malaise: A Randomized, Placebo-Controlled, Double-Blind Clinical Study in Patients with Unresectable Metastatic Colorectal Cancer (KSCC1402/HGCSG1402)
Hiroaki Tanioka, Yuji Miyamoto, Akihito Tsuji et al. · Oncology
|
2018 |
8 |
| 34 |
Prospects for Harmonizing Regulatory Science Programs in Europe, Japan, and the United States to Advance Regenerative Medicine
Christopher‐Paul Milne, James Mittra, Naoko Kojima et al. · Therapeutic Innovation & Regulatory Science
Open access |
27 May 2016 |
8 |
| 35 |
Prophylactic treatment of dacomitinib‐induced skin toxicities in epidermal growth factor receptor‐mutated non–small‐cell lung cancer: A multicenter, Phase II trial
Masahiro Iwasaku, Junji Uchino, Kenji Chibana et al. · Cancer Medicine
Open access |
3 Jun 2023 |
7 |
| 36 |
Phase II Study of Nivolumab Plus Ipilimumab with Platinum-Based Chemotherapy for Treatment-Naïve Advanced Non-Small Cell Lung Cancer with Untreated Brain Metastases: NIke Trial (LOGiK2004)
Yuko Tsuchiya‐Kawano, Yoshimasa Shiraishi, Fumiaki Kiyomi et al. · Cancer Management and Research
Open access |
Nov 2021 |
7 |
| 37 |
Efficacy and safety of switching to nilotinib in patients with CML-CP in major molecular response to imatinib: results of a multicenter phase II trial (NILSw trial)
Jun Ishikawa, Itaru Matsumura, Tatsuya Kawaguchi et al. · International Journal of Hematology
|
23 Jan 2018 |
7 |
| 38 |
Platinum plus etoposide with durvalumab for extensive-stage small-cell lung cancer with untreated brain metastases: a multicenter, single-arm phase II trial (LOGiK2001, SPEED)
Yoshimasa Shiraishi et al. · ESMO Open
Open access |
Jul 2025 |
6 |
| 39 |
Update of prognosis and characteristics of chronic obstructive pulmonary disease in a real-world setting: a 5-year follow-up analysis of a multi-institutional registry
Tomotsugu Takano et al. · BMC Pulmonary Medicine
Open access |
6 Nov 2024 |
6 |
| 40 |
Phase II study of durvalumab ( MEDI 4736) plus carboplatin and etoposide in elderly patients with extensive stage small cell lung cancer: Study protocol of turtle study ( LOGIK 2003)
Hidenobu Ishii, Koichi Azuma, Takayuki Shimose et al. · Thoracic Cancer
Open access |
15 Nov 2022 |
5 |
| 41 |
The Impact of Street Food Stalls on the Local Economy and Conditions for their Sustainable Management
Kazuro Yahiro, Satoshi Toi, Yuki Nagashima · QIR (Kyushu University Institutional Repository) (Kyushu University)
Open access |
24 Jun 2013 |
5 |
| 42 |
Usefulness of virtual scale endoscope for early gastrointestinal lesions
Nobuhisa Minakata, Hiroaki Ikematsu, Fumiaki Kiyomi et al. · DEN Open
Open access |
18 Jun 2024 |
3 |
| 43 |
Effects of pericapsular soft tissue and realignment exercises for patients with osteoarthritis of the hip and Harris Hip Score below 60 points
Kazuo Hayashi, Toshiharu Tsunoda, Yuki Tobo et al. · Current Medical Research and Opinion
Open access |
11 Jun 2022 |
3 |
| 44 |
Rationale and design of a phase II study to evaluate prophylactic treatment of dacomitinib-induced dermatologic adverse events in epidermal growth factor receptor-mutated advanced non-small cell lung cancer (SPIRAL-Daco study)
Masahiro Iwasaku, Junji Uchino, Tadaaki Yamada et al. · Translational Lung Cancer Research
Open access |
Aug 2019 |
3 |
| 45 |
Study protocol of an open-label prospective phase II study of Durvalumab plus Carboplatin and Etoposide in advanced large cell neuroendocrine carcinoma of the lung (LOGIK2401: NECTAR study)
Hidenobu Ishii, Koichi Azuma, Fumiaki Kiyomi et al. · Cancer Treatment and Research Communications
Open access |
2025 |
2 |
| 46 |
A phase II study of weekly carboplatin and concurrent radiotherapy in older adults with locally advanced non‐small cell lung cancer ( LOGIK1902 )
Taishi Harada, Tomonari Sasaki, Hidenobu Ishii et al. · Thoracic Cancer
Open access |
8 Sep 2024 |
2 |
| 47 |
Safety and Efficacy of Cryotherapy for the Treatment of Renal Angiomyolipoma Related to Tuberous Sclerosis Complex: The Cryo-TSC Study
Eiji Kashiwagi et al. · JU Open Plus
Open access |
Jun 2024 |
2 |
| 48 |
Phase II study of carboplatin/nab-paclitaxel/atezolizumab combination therapy for advanced nonsquamous non–small cell lung cancer patients with impaired renal function: RESTART trial
Yoshimasa Shiraishi, Junji Kishimoto, Takayuki Shimose et al. · BMC Cancer
Open access |
8 Sep 2022 |
2 |
| 49 |
A phase I/II study of S-1 and irinotecan (IRIS) combined with cetuximab in patients with RAS wild-type metastatic colorectal cancer (KSCC1401)
Hironori Samura, Eiji Oki, Hiroshi Okumura et al. · Cancer Chemotherapy and Pharmacology
|
30 Jul 2020 |
2 |
| 50 |
An Observational Study of Team Management Approach for CapeOX Therapy in Patients with Advanced and Recurrent Colorectal Cancer: SMILE Study (The Study of Metastatic colorectal cancer to investigate the Impact of Learning Effect)
Hiroshi Matsuoka, Yutaka Ogata, Michio Nakamura et al. · Journal of the Anus Rectum and Colon
Open access |
27 Apr 2020 |
2 |